These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22922321)

  • 1. Unsatisfactory outcomes of prolonged ischemic priapism without early surgical shunts: our clinical experience and a review of the literature.
    Zheng DC; Yao HJ; Zhang K; Xu MX; Chen Q; Chen YB; Cai ZK; Lu MJ; Wang Z
    Asian J Androl; 2013 Jan; 15(1):75-8. PubMed ID: 22922321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomic and Functional Outcome Following Distal Shunt and Tunneling for Treatment İschemic Priapism: A Single-Center Experience.
    Ortaç M; Çevik G; Akdere H; Ermeç B; Kadıoğlu A
    J Sex Med; 2019 Aug; 16(8):1290-1296. PubMed ID: 31230939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease status and outcomes of African-American men presenting with priapism.
    Bennett N; Mulhall J
    J Sex Med; 2008 May; 5(5):1244-1250. PubMed ID: 18312286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of the efficacy and safety of sildenafil administered to patients with erectile dysfunction referred for posterior urethroplasty: a single-center experience.
    Fu Q; Sun X; Tang C; Cui R; Chen L
    J Sex Med; 2012 Jan; 9(1):282-7. PubMed ID: 21933349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Al-Ghorab Shunt plus intracavernous tunneling for prolonged ischemic priapism.
    Lian W; Lv J; Cui W; Jin Z; Liu T; Li W; Yuan Y; Xin Z
    J Androl; 2010; 31(5):466-71. PubMed ID: 20467049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease.
    Burnett AL; Anele UA; Trueheart IN; Strouse JJ; Casella JF
    Am J Med; 2014 Jul; 127(7):664-8. PubMed ID: 24680796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corporal Burnett "Snake" surgical maneuver for the treatment of ischemic priapism: long-term followup.
    Segal RL; Readal N; Pierorazio PM; Burnett AL; Bivalacqua TJ
    J Urol; 2013 Mar; 189(3):1025-9. PubMed ID: 23017524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of the T-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism.
    Zacharakis E; Raheem AA; Freeman A; Skolarikos A; Garaffa G; Christopher AN; Muneer A; Ralph DJ
    J Urol; 2014 Jan; 191(1):164-8. PubMed ID: 23892191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Priapism: decisional algorithm. Our experience and role of sildenafil in sexual rehabilitation].
    De Rose AF; Corbu C; De Caro G; Simonato A; Carmignani G
    Arch Ital Urol Androl; 2000 Jun; 72(2):45-50. PubMed ID: 10953389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil citrate-associated priapism.
    Sur RL; Kane CJ
    Urology; 2000 Jun; 55(6):950. PubMed ID: 10840123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of Ischemic and Non-ischemic Priapism.
    Biebel MG; Gross MS; Munarriz R
    Curr Urol Rep; 2022 Jul; 23(7):143-153. PubMed ID: 35536499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischemic priapism in South-East Nigeria: Presentation, management challenges, and aftermath issues.
    Ugwumba FO; Ekwedigwe HC; Echetabu KN; Okoh AD; Nnabugwu I; Ugwuidu ES
    Niger J Clin Pract; 2016; 19(2):207-11. PubMed ID: 26856282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical outcomes of the Burnett "snake" maneuver shunt modification for ischemic priapism.
    Unal S; Karakus S; Du Comb W; Burnett AL
    J Sex Med; 2024 Aug; 21(8):723-728. PubMed ID: 38971576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatment options for erectile dysfunction in patients with diabetes mellitus.
    Basu A; Ryder RE
    Drugs; 2004; 64(23):2667-88. PubMed ID: 15537369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Priapism: decisional algorithm, our experience, and role of sildenafil in sexual rehabilitation].
    De Rose AF; Corbu C; De Caro G; Bonini F; Carmignani G
    Arch Ital Urol Androl; 2001 Mar; 73(1):27-32. PubMed ID: 11505810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-flow priapism: risk factors for erectile dysfunction.
    El-Bahnasawy MS; Dawood A; Farouk A
    BJU Int; 2002 Feb; 89(3):285-90. PubMed ID: 11856112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of sildenafil citrate in the treatment of erectile dysfunction in patients with ischemic heart disease.
    Conti CR; Pepine CJ; Sweeney M
    Am J Cardiol; 1999 Mar; 83(5A):29C-34C. PubMed ID: 10078540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distal corpus cavernosum fibrosis and erectile dysfunction secondary to non-ischaemic priapism.
    Zacharakis E; Ralph DJ; Walkden M; Muneer A
    Arch Ital Urol Androl; 2015 Sep; 87(3):258-9. PubMed ID: 26428655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of shunt surgery for refractory low flow priapism: a report on the incidence of failed detumescence and erectile dysfunction.
    Nixon RG; O'Connor JL; Milam DF
    J Urol; 2003 Sep; 170(3):883-6. PubMed ID: 12913722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the association between erectile rigidity and treatment adherence with sildenafil.
    Mazzola CR; Deveci S; Teloken P; Mulhall JP
    J Sex Med; 2013 Jul; 10(7):1861-6. PubMed ID: 23253943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.